Saluja Manjit - Ctr Rheumat Dis | 人才画像

& nbsp;Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol (vol 9, 761655, 2022)

Arvind Chopra,Preeti Chavan-Gautam,Girish Tillu,Manjit Saluja,Swapnil Borse,Sanjeev Sarmukaddam,Susmita Chaudhuri,B. C. S. Rao,Babita Yadav,Narayanam Srikanth,Bhushan Patwardhan

FRONTIERS IN MEDICINE（2022）

Cited0Views0Bibtex

Adjunct Therapeutic Role of Potassium in Rheumatoid Arthritis: A Randomized Controlled Trial with Suitable Diet and Novel Food Supplement in Symptomatic Patients on Standard Rheumatology Care

Toktam Kianifard,Manjit Saluja,Sanjeev Sarmukaddam,Anuradha Venugopalan,Arvind Chopra

crossref（2022）

Cited0Views0Bibtex

Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol

Arvind Chopra,Preeti Chavan-Gautam,Girish Tillu,Manjit Saluja,Swapnil Borse,Sanjeev Sarmukaddam,Susmita Chaudhuri,Bcs Rao,Babita Yadav,Narayanam Srikanth,Bhushan Patwardhan

FRONTIERS IN MEDICINE（2022）

Cited6Views0WOSBibtex

Randomized, double blind, placebo controlled, clinical trial to study co-administration of Ashwagandha on safety, immunogenicity, and protection with COVID-19 vaccine: A Study Protocol

A. Chopra,P. Gautam,G. Tillu,M. Saluja,S. Borse,Sanjeev Balwant Sarmukaddam,S. Chaudhuri,B. Rao,B. Yadav,Narayanam Srikanth,B. Patwardhan

medRxiv (2021)

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn